Gainesville, FL: The twice-daily use of hemp-derived CBD oil extracts reduces muscle-injury-related pain and induces recovery, according to placebo-controlled data published in the Journal of Cannabis Research.
Investigators affiliated with the University of Florida at Gainesville compared the safety and efficacy of hemp-derived CBD versus a placebo in healthy adults. Study participants consumed either CBD-infused tinctures or the placebo sublingually for 15 days. On day 10, participants completed sets of repetitive exercises to induce musculoskeletal pain, strength loss, and disability.
Those who consumed CBD extracts reported less pain, strength loss, and physical disability following completion of the experimental injury protocol. They also required slightly less time to fully recover from their injuries. The CBD intervention was described as safe and well-tolerated.
“Improving time to recovery after musculoskeletal injury is a highly reported topic of interest in sports science and athletic healthcare,” the study’s authors concluded. “CBD administered sublingually demonstrated a favorable safety profile and showed promise in reducing symptoms associated with a musculoskeletal injury. Clinical studies using larger sample sizes and broader dose-ranges are needed to confirm the reported trends in controlling pain and function post-injury.”
Last week, the Centers for Medicare & Medicaid Services launched a pilot program providing eligible hemp-derived products to Medicare beneficiaries.
Full text of the study, “Efficacy and safety of cannabidiol on reducing pain and functional impairment associated with exercise-induced muscle injury: A randomized placebo-controlled feasibility trial,” appears in the Journal of Cannabis Research.